Literature DB >> 15610647

Cardiovascular magnetic resonance and the evaluation of heart failure.

James C C Moon1, Sanjay K Prasad.   

Abstract

Cardiovascular magnetic resonance (CMR) has established itself as probably the single best way of phenotyping the failing heart. It is the accepted gold standard for measuring cardiac function, volumes, and mass, but within the same scan session additional techniques are available for greater definition. Tissue characterization with the contrast agent gadolinium is well validated and allows the precise visualization and quantification of myocardial infarction. This can be used for viability assessment and to determine heart failure etiology. Dobutamine stress CMR and CMR perfusion hold advantages over conventional techniques. The new frontiers of CMR in heart failure hold the promise of unique insights quantifying myocardial iron, nonischemic fibrosis, microvascular perfusion, plaque characterization, and CMR-targeted intervention. The development and validation of these techniques represent major research challenges for the future. From a clinical perspective, an equal challenge is in increasing the availability of the modality for patients and physicians.

Entities:  

Mesh:

Year:  2005        PMID: 15610647     DOI: 10.1007/s11886-005-0009-3

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  46 in total

1.  Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable?

Authors:  N G Bellenger; M I Burgess; S G Ray; A Lahiri; A J Coats; J G Cleland; D J Pennell
Journal:  Eur Heart J       Date:  2000-08       Impact factor: 29.983

2.  MRI of cardiac morphology and function after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.

Authors:  Yasuo Amano; Morimasa Takayama; Maki Amano; Tatsuo Kumazaki
Journal:  AJR Am J Roentgenol       Date:  2004-02       Impact factor: 3.959

Review 3.  Integrated approach to ischemic heart disease. The one-stop shop.

Authors:  C M Kramer
Journal:  Cardiol Clin       Date:  1998-05       Impact factor: 2.213

4.  An improved MR imaging technique for the visualization of myocardial infarction.

Authors:  O P Simonetti; R J Kim; D S Fieno; H B Hillenbrand; E Wu; J M Bundy; J P Finn; R M Judd
Journal:  Radiology       Date:  2001-01       Impact factor: 11.105

5.  Identification of fibrous cap rupture with magnetic resonance imaging is highly associated with recent transient ischemic attack or stroke.

Authors:  Chun Yuan; Shao-xiong Zhang; Nayak L Polissar; Denise Echelard; Geraldo Ortiz; Joseph W Davis; Elizabeth Ellington; Marina S Ferguson; Thomas S Hatsukami
Journal:  Circulation       Date:  2002-01-15       Impact factor: 29.690

6.  Treatment of claustrophobia for cardiovascular magnetic resonance: use and effectiveness of mild sedation.

Authors:  J M Francis; D J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2000       Impact factor: 5.364

7.  Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography.

Authors:  E Nagel; H B Lehmkuhl; W Bocksch; C Klein; U Vogel; E Frantz; A Ellmer; S Dreysse; E Fleck
Journal:  Circulation       Date:  1999-02-16       Impact factor: 29.690

8.  Infarct resorption, compensatory hypertrophy, and differing patterns of ventricular remodeling following myocardial infarctions of varying size.

Authors:  David S Fieno; Hanns B Hillenbrand; Wolfgang G Rehwald; Kathleen R Harris; Robert S Decker; Michele A Parker; Francis J Klocke; Raymond J Kim; Robert M Judd
Journal:  J Am Coll Cardiol       Date:  2004-06-02       Impact factor: 24.094

9.  A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload.

Authors:  Mark Westwood; Lisa J Anderson; David N Firmin; Peter D Gatehouse; Clare C Charrier; Beatrix Wonke; Dudley J Pennell
Journal:  J Magn Reson Imaging       Date:  2003-07       Impact factor: 4.813

10.  Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium.

Authors:  James C C Moon; Bhavesh Sachdev; Andrew G Elkington; William J McKenna; Atul Mehta; Dudley J Pennell; Philip J Leed; Perry M Elliott
Journal:  Eur Heart J       Date:  2003-12       Impact factor: 29.983

View more
  2 in total

1.  Prevalence and prognostic significance of left ventricular myocardial late gadolinium enhancement in severe aortic stenosis.

Authors:  Gopalan Nair Rajesh; Julian Johny Thottian; Gomathy Subramaniam; Vinayakumar Desabandhu; Chakanalil Govindan Sajeev; Mangalath Narayanan Krishnan
Journal:  Indian Heart J       Date:  2017-06-01

Review 2.  Imaging of Myocardial Fibrosis in Patients with End-Stage Renal Disease: Current Limitations and Future Possibilities.

Authors:  M P M Graham-Brown; A S Patel; D J Stensel; D S March; A-M Marsh; J McAdam; G P McCann; J O Burton
Journal:  Biomed Res Int       Date:  2017-03-02       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.